Aycock R. L., Bradshaw A. C., Sage E. H., Starcher B.. Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC. Journal of Investigative Dermatology 2004; 123 (3):592-599.
Aziz T. A., Pereira N. L.. Electrocardiographic changes simulating a myocardial infarction after cardiac transplantation. Journal of Heart and Lung Transplantation 2004; 23 (11):1301-1303.
Baicu S. C., Simmons P. M., Campbell L. H., Taylor M. J., Brockbank K. G.. Interstitial fluid analysis for assessment of organ function. Clin. Transplant. 2004; 18 (S12):16-21.
Baker S. D., Horger D. C., Keane T. E.. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology 2004; 64 (4):.
Baliga P., Alvarez S., Lindblad A., Zeng L.. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transplantation 2004; 10 (11):1364-1371.
Baliga P., Alvarez S., Lindblad A., Zeng L., Studies of Pediatric Liver Transplantation Research Group. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transplantation 2004; 10 (11):1364-71.
Baliga P., Odom S., Gilbert G., Turissi K., Lin A., Afzal F., Emmovon O., Rogers J., Rajagopalan P. R., Chavin K.. Resource utilization in cadaver renal transplantion. American Journal of Transplantation 2004; 4 ():428-428.
Baliga P., Smalls G., Gilbert G., Shilling L., Martin M., Norman M., Milton J., Hildebrand L., Chavin K.. A prospective survey of concerns in kidney transplantation: Donor and recipient perspectives. American Journal of Transplantation 2004; 4 ():373-373.
Ball L. E., Garland D. L., Crouch R. K., Schey K. L.. Post-translational modifications of Aquaporin 0 (AQP0) in the normal human lens: Spatial and temporal occurrence. Biochemistry 2004; 43 (30):9856-9865.
Ballenger J. C.. Remission rates in patients with anxiety disorders treated with paroxetine. Journal of Clinical Psychiatry 2004; 65 (12):1696-1707.
Bandyopadhyay A., Beeson C., Sant A.. Binding energetics of peptide binding to MHC II protein (I-Ak). Faseb Journal 2004; 18 (8):C190-C191.
Banik N. L., Das A., Wingrave J. M., Wilford G. G., Delre A. M., Woodward J. J., Appel S. H., Ray S. K.. Calpain inhibition provided functional neuroprotection in VSC4.1 motoneurons exposed to glutamate. Journal of Neurochemistry 2004; 90 ():18-18.
Banik N. L., Guyton M. K., Sribnick E. A., Matzelle D. D., Wingrave J. M., Ray S. K.. Role of calpain in demyelination and neurodegeneration in EAE. Journal of Neurochemistry 2004; 90 ():53-53.
Barfield W. R.. Comment: "Role of perceptual and motor abilities in instep kicking performance of young soccer players" by Zisi, Derri, and Hatzitaki.[comment]. Perceptual and Motor Skills 2004; 99 (3 Pt 1):811-2.
Barfield W. R., Gross R. H., Cook M.. Codetron as an adjunctative treatment modality in pediatric patients following spinal surgery. Medicine and Science in Sports and Exercise 2004; 36 (5):S14-S15.
Baris D., Silverman D. T., Brown L. M., Swanson G. M., Hayes R. B., Schwartz A. G., Liff J. M., Schoenberg J. B., Pottern L. M., Greenberg R. S., Stewart P. A.. Occupation, pesticide exposure and risk of multiple myeloma. Scandinavian Journal of Work Environment and Health 2004; 30 (3):215-222.
Barkley R. A.. Driving impairments in teens and adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am. 2004; 27 (2):233-60.
Barkley R. A.. Adolescents with attention-deficit/hyperactivity disorder: an overview of empiracally-based treatments. Journal of Psychiatric Practice 2004; 10 (1):39-56.
Barkley R. A.. Adolescents with attention-deficit/hyperactivity disorder: an overview of empirically based treatments. Journal of Psychiatric Practice 2004; 10 (1):39-56.
Barkley R. A., Fischer M., Smallish L., Fletcher K.. Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry 2004; 45 (2):195-211.
Barredo J. C., Altman-Hamandzic S., Leclerc G. J.. Differences in folylpoly-gamma-glutamate synthetase (FPGS) expression in childhood ALL result from cell lineage of origin and presence of non-random translocations. Blood 2004; 104 (11):574A-575A.
Barredo J. C., Altman-Hamandzic S., Leclerc G. J.. Differences in folylpoly-gamma-glutamate synthetase (FPGS) expression in childhood ALL result from cell lineage of origin and presence of non-random translocations. Blood 2004; 104 (11):574A.
Basco W. T., Lancaster C., Carey M. E., Gilbert G. E., Blue A. V.. The medical school applicant interview predicts performance on a fourth-year clinical practice examination. Pediatric Research 2004; 55 (4):350A-350A.
Basile Jan N., Lackland Daniel T., Basile Jeffrey M., Riehle Jessica E., Egan Brent M.. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. Journal of Clinical Hypertension 2004; 6 (1):18-25.
Basile J.. The role of existing and newer calcium channel blockers in the treatment of hypertension. Journal of Clinical Hypertension 2004; 6 (11):621-29.
Basile J. N.. Angiotensin receptor blocker equivalent to a proven angiotensin-converting enzyme inhibitor postmyocardial infarction. Journal of Clinical Hypertension 2004; 6 (3):150-151.
Basile Jan. Analysis of recent papers in hypertension. Journal of Clinical Hypertension 2004; 6 (1):40-1.
Basile L. A., Katikaneni L. D., Ebeling M., Fessler C., Southgate W. M.. Cerebellar hermorrhage in the extremely preterm infant: Epidemiology and neurodevelopmental follow-up. Pediatric Research 2004; 55 (4):374A-374A.
Basile L. A., Macias M., Halsey T. C., Katikaneni L. D.. Predictors of neurodevelopmental outcomes in 23 to 25 week gestation infants. Pediatric Research 2004; 55 (4):481A-481A.
Basso J. A., Mauldin P. D.. Effects of formulary addition of cefepime on susceptibility of select Gram-negative pathogens to ceftazidime and imipenem: analysis by interrupted time series analysis. Pharmacotherapy 2004; 24 (10):1442-1442.
Batalis N. I., Prahlow J. A.. Accidental insulin overdose. Journal of Forensic Sciences 2004; 49 (5):1117-1120.
Bayer A., Weiler W., Oeverhaus U., Skrotzki F. E., Stewart W. C., Xplore Observation Group. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies. Journal of Ocular Pharmacology and Therapeutics 2004; 20 (6):470-8.
Bazzoli G. J., Lindrooth R. C., Hasnain-Wynia R., Needleman J.. The balanced budget act of 1997 and U.S. Hospital operations. Inquiry-the Journal of Health Care Organization Provision and Financing 2004; 41 (4):401-417.
Becker H. C., Crissman A. M., Studders S., Kelley B. M., Middaugh L. D.. Differential neurosensitivity to the discriminative stimulus properties of ethanol in C57BL/6J and C3H/He mice. Alcoholism Clinical and Experimental Research 2004; 28 (5):712-9.
Becker H. C., Lopez M. F.. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcoholism-Clinical and Experimental Research 2004; 28 (12):1829-1838.
Becker H. C., Lopez M. F.. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcoholism: Clinical and Experimental Research 2004; 28 (12):1829-38.
Becker K. P., Hannun Y. A.. Isoenzyme-specific translocation of protein kinase C (PKC) beta II and not PKC beta I to a juxtanuclear subset of recycling endosomes - Involvement of phospholipase D. Journal of Biological Chemistry 2004; 279 (27):28251-28256.
Bedard P., Proteau L.. On-line vs. off-line utilization of peripheral visual afferent information to ensure spatial accuracy of goal-directed movements. Experimental Brain Research 2004; 155 (online first):.
Bell N. H.. Editorial: Bone loss and gastric bypass surgery for morbid obesity. Journal of Clinical Endocrinology and Metabolism 2004; 89 (3):1059-1060.
Bellamy S. L., Yi L., Ryan L. M., Lipsitz S., Canner M. J., Wright R.. Analysis of clustered and interval censored data from a community-based study in asthma. Statistics in Medicine 2004; 23 (23):3607-3621.
Benbenisty K. M., Lang P. G. Jr., Maize J. C.. Extensive angiosarcoma on chronically sun-damaged skin. American Journal of Clinical Dermatology 2004; 5 (1):53-55.
Benbenisty K. M., Lang P. G., Maize J. C.. Extensive angiosarcoma on chronically sun-damaged skin. American Journal of Clinical Dermatology 2004; 5 (1):53-5.
Bennett D. S., Pitale M., Vora V., Rheingold A. A.. Reactive vs. proactive antisocial behavior: differential correlates of child ADHD symptoms?. Journal of Attention Disorders 2004; 7 ():197-204.
Beon M., Harley R. A., Wessels A., Silver R. M., Ludwicka-Bradley A.. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clinical and Experimental Rheumatology 2004; 22 (6):733-742.
Beon M., Harley R. A., Wessels A., Silver R. M., Ludwicka-Bradley A.. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clinical and Experimental Rheumatology 2004; 22 (6):733-42.
Berghella V., Iams J. D., Newman R. B., MacPherson C., Goldenberg R. L., Mueller-Heubach E., Caritis S. N., Dombrowski M. P.. Frequency of uterine contractions in asymptomatic pregnant women with or without a short cervix on transvaginal ultrasound scan. American Journal of Obstetrics and Gynecology 2004; 191 (4):1253-1256.
Berkman S. C., Ashcraft E., Baillie G. M., Taber D., Lin A., Rogers J., Baliga P., Chavin K. D.. Valganciclovir for CMV prophylaxis in liver transplant recipients: An initial experience. American Journal of Transplantation 2004; 4 ():358-358.
Bestermann W. H., Lackland D. T., Riehle J. E., Egan B. M.. A systematic approach to managing hypertension and the metabolic syndrome in primary care. Southern Medical Journal 2004; 97 (10):932-938.
Bhat N. R., Quintero E. M., Fan F., Shen Q.. Elixir(LXR)s for modulating glial functions: suppression of inflammatory response and stimulation of myelin gene expression. Journal of Neurochemistry 2004; 90 ():103-103.
Bhat N., Quintero E. M., Shen Q.. LXR inhibition of glial inflammatory response. Faseb Journal 2004; 18 (8):C213-C214.
